Standex International (SXI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for October 22, 2024, at the company headquarters in Salem, NH, with shareholders of record as of August 28, 2024, eligible to vote on key proposals.
Shareholders can vote in person, by mail, phone, or online, with proxy solicitation costs covered by the company and Alliance Advisors assisting in the process.
The board recommends voting in favor of all proposals, including director elections, incentive plan amendment, executive compensation, by-law amendment, and auditor ratification.
Voting matters and shareholder proposals
Election of three directors for three-year terms expiring in 2027.
Amendment to the 2018 Omnibus Incentive Plan to add 450,000 shares for future equity awards.
Advisory vote on executive compensation (say-on-pay).
Amendment to by-laws allowing the board, in addition to shareholders, to set the number of directors within a prescribed range.
Ratification of Deloitte & Touche LLP as independent auditors for FY 2025.
Board of directors and corporate governance
Board consists of eight directors, with three classes serving staggered three-year terms.
All non-employee directors are independent; board committees are composed solely of independent directors.
Regular board and committee self-evaluations, mandatory retirement age of 75, and ongoing board refreshment with a focus on diversity.
Board leadership structure includes a combined Chair/CEO, Lead Independent Director, and annual review of leadership roles.
Four standing committees: Audit, Compensation, Nominating & Corporate Governance, and Innovation & Technology.
Board and committees oversee risk, strategy, ESG, and compliance.
Latest events from Standex International
- Record profit, margin gains, and new launches set up >20% fast market growth for FY25.SXI
Q4 20242 Feb 2026 - Q2 FY26 delivered double-digit sales growth, margin expansion, and record order intake.SXI
Q2 20262 Feb 2026 - Record margin and a $462M acquisition set the stage for sequential growth.SXI
Q1 202518 Jan 2026 - Record sales and margins driven by acquisitions, but net income and cash flow declined.SXI
Q2 20259 Jan 2026 - Record margins and 17.2% sales growth driven by acquisitions and fast growth markets.SXI
Q3 202523 Dec 2025 - Proxy covers director elections, pay, governance, risk, and ESG, with all proposals recommended.SXI
Proxy Filing1 Dec 2025 - 2025 meeting covers director elections, say-on-pay, auditor ratification, and ESG priorities.SXI
Proxy Filing1 Dec 2025 - Shareholders will vote on a By-Law Amendment needing 80% approval, with Board support.SXI
Proxy Filing1 Dec 2025 - Record Q4 sales and margin expansion set up $100M+ revenue growth and new launches in FY26.SXI
Q4 202516 Nov 2025